Pear’s apps guide users through behavioral therapy. Pear Therapeutics, which has three FDA-cleared prescription apps to help treat substance use disorder and insomnia, filed for bankruptcy on ...

Pear Therapeutics was one of the most notable companies in digital therapeutics and its downfall could be an ominous sign for other industry players. “I worry it’s a signal for the immediate ...

Less than two years after Pear Therapeutics went public in a SPAC deal worth $1.6 billion—which in turn came after the digital therapeutics maker had raised more than $400 million in venture ...

Digital therapeutics company Pear Therapeutics is making cuts in nearly all areas of its business, a move that buys the company time as it works to grow revenue for its small slate of ...

Pear Therapeutics aimed to disrupt healthcare by offering software as medicine. Though the company succeeded in bringing three prescription digital therapeutics products to the market, Pear was ...

Pear ended last year with 14,000 prescriptions written for its addiction, opioid use disorder and insomnia digital therapeutics, above its forecast of 12,500. The goal for 2022 is to have 50,000 ...

Four different companies agreed to buy the assets of Pear Therapeutics at auction on Thursday morning after the digital health company filed for bankruptcy last month. Click Therapeutics ...

The digital-therapeutics pioneer Pear was sold for parts in an auction on May 18 for $6 million. Companies like Pear and Akili have struggled to get payers and providers on board with their tech.